Table 1.
Cognitive domains and functions assessed in the St Göran bipolar project.
Table 2.
Demographics and clinical characteristics of patients with bipolar disorder type I and II and healthy controls.
Table 3.
Cognitive performance for patients with bipolar disorder and healthy controls.
Table 4.
Cerebrospinal fluid biomarkers associated with cognitive performance in bipolar disorder.
Fig 1.
Association between actual and predicted visuospatial score in bipolar patients and healthy controls.
Figures display actual and predicted visuospatial performance in z-scores in bipolar disorder (1A) and healthy controls (1B). In patients with bipolar disorder cerebrospinal fluid (CSF) Amyloid β (Aβ) 42/40 ratio, CSF Aβ42/38 ratio, CSF total tau, age, and lithium contributed significantly to the model (adj. r2 =. 36, p = <.0005). In patients with bipolar disorder only sex and age were associated with visuospatial functions (adj. r2 =. 23, p = <.0005).
Table 5.
Variables associated with cognitive performance in healthy controls.